from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3502c/-

LFCtreatmentdescriptionclass of inhibitor

0.328

Amikacinug/mL Amikacintranslation

0.813

Cap5-10ug/mL Capreomycintranslation

1.490

Rox10-50 ug/mL Roxithromycintranslation

-0.183

SM2-5 ug/mL Streptomycintranslation

1.762

Tet5-10 ug/mL Tetracyclinetranslation

-0.350

Rif0.2-5ug/mL Rifampicintranscription

-0.163

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.411

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.501

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.199

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.196

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.596

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.722

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

3.368

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.829

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.081

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.008

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.263

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.310

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.304

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.828

KCN5-20 ug/mL Potassium cyaniderespiration

-0.699

NaN30.2-2 mM Sodium aziderespiration

0.537

Nigericin50 uM Nigericinrespiration

1.147

TRC10-150 ug/mL Triclosanrespiration

0.095

TRZ10-25 ug/mL Thioridazinerespiration

-0.207

Valinomycin0.5-10 uM Valinomycinrespiration

-1.704

ZnSO42 mM ZnSO4respiration

0.281

menadione6-10 ug/mL Menadionerespiration

0.842

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.335

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.269

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.500

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.020

NRP_1Non-replicating persistence stage 1dosRassociated

-0.548

Amp0.2mg/mL AmpicillincellWall

-0.632

Cephalexin20-100 ug/mL CephalexincellWall

-0.423

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.350

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.665

EMB10-20 ug/mL EthambutolcellWall

-0.296

Eta12-40 ug/mL EthionamidecellWall

-0.453

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.486

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.600

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.601

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.553

BZA0.12 mg/mL BenzamidearomaticAmides

0.515

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.050

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.300

H2O24 mM hydrogen peroxideDNAdamaging

-1.182

Levo10 ug/mL LevofloxacinDNAdamaging

-0.044

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.019

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.932

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.297

UVUV-irradiationDNAdamaging

0.786

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.652

Antimycin12.5-50 ug/mL Antimycin A?

-0.401

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.646

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.389

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.053

PA8240.2-2 ug/mL PA-824?

1.417

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.288

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.425

Verapamil50 uM Verapamil?

-1.081

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.543

methoxatin10-20 ug/mL Methoxatin?